Suggestions
Don Taylor
Retired professional with extensive experience in the collections and ARM industries
Don Taylor is an accomplished technology licensing executive with a wealth of experience in the academic sector. He studied Bioengineering, earning both a Ph.D. and an M.S. from the University of Pittsburgh. He continued his education with an MBA from the Joseph M. Katz Graduate School of Business at the same institution. Taylor also holds a B.S. in Information Systems from Carnegie Mellon University.
Currently serving as the Executive Director of Licensing at The Ohio State University, Taylor has also held several academic positions, including Senior Lecturer at Carnegie Mellon University, Associate Professor of Biomedical Informatics at the University of Pittsburgh, and Co-Director of the Center for Commercial Applications of Healthcare Data. Before joining Ohio State, Taylor founded and served as Executive Director for sciVelo, a program designed to transform research discoveries into commercial products.
Taylor's industry experience is equally impressive. He has held senior leadership positions at healthStratica, bioStratica, and Cellumen, among others. Taylor was also the President and CEO of Net Health Systems, Inc., a company he co-founded.
In addition to his academic and industry work, Taylor has lectured, published and presented on various topics related to technology licensing and commercialization. He is a sought-after speaker and a recognized industry expert.
With his extensive background in technology licensing, business development, and executive leadership, Don Taylor is a valuable asset to any team.
Highlights
🚀 Introducing the UC Davis Health Ventures Webinar Series: From Lab to Life
From the UC Davis Innovation and Economic Development Office led by George Baxter, and CEO of UC Davis Health, David Lubarsky, we're excited to announce the launch of an innovative monthly webinar series dedicated to advancing human health research and innovation!🌟
From Lab to Life is not just another webinar series—it's a dynamic journey designed for all University of California, Davis faculty, staff, and students eager to transform their human health research into clinical impact. This series connects you with the many key offices across UC Davis and UC Davis Health that drive research translation, simplifying the process for innovators to efficiently tap into this extensive support network.
What sets this series apart? The #collaboration among our presenters from the many offices, who are committed to making the complex world of research translation not just accessible but inspiring. Expect storytelling that captivates and practical takeaways that empower you to think big and execute on your research impact. 🚀
The first session is on Intellectual Property (IP) and delivered by UC Davis Venture Catalyst (Mike Lemcke), UC Davis Technology Transfer Office (Pooja Bhayani MS, MBA) and UC Davis Health Ventures (Chris Loryman).
Topics include: 🔍 The Power of IP: Discover how protecting intellectual property can fuel both societal benefits and financial returns, all while advancing patient care and human health.
🔒 Safeguarding Innovations: Learn the critical steps to protect your IP from accidental disclosure and navigate the invention 'ROI' filing process.
🎯 Strategic IP Development: Uncover strategies to maximize the IP's value, ensuring your innovations make a lasting impact.
📅 Date: September 4 ⏰ Time: 12:00 - 12:50 PM
If you're with UC Davis and haven't registered yet, contact [email protected] for your invite!
🌟 Driving Innovation: Transformative Investments in Human Health🌟 Read story here: https://lnkd.in/gA-E-UcX
Thanks to the generous funding from David Lubarsky of UC Davis Health, we are making transformative investments in research translation. These efforts focus on breakthrough projects, including early cancer detection (https://lnkd.in/gdxj9Pjv), speech restoration for individuals with disabilities (https://lnkd.in/gWZTtMC9), and the development of novel therapies for Parkinson’s disease (https://lnkd.in/gMvCFJmT). In collaboration with UC Davis Venture Catalyst, UC Davis Technology Transfer Office, and UC Davis Health Ventures, we are driving these pioneering projects toward clinical impact. This partnership fuels a virtuous cycle of innovation, propelling research forward and diversifying financial resources to fulfill our mission of delivering Tomorrow's Health Care Today.
Read story here: https://lnkd.in/gA-E-UcX
